background
aetiolog
lower
respiratori
tract
infect
challeng
investig
despit
wide
array
diagnost
tool
invas
techniqu
bronchoalveolar
lavag
bal
often
requir
obtain
adequ
specimen
pneumoniacheck
tm
new
devic
collect
aerosol
particl
cough
allow
microbiolog
analys
test
bacteria
detect
studi
investig
use
viru
identif
method
pilot
studi
includ
consecut
patient
pneumonia
test
cough
adequaci
via
peak
flow
meter
sampl
pneumoniacheck
tm
collect
bal
perform
patient
microbiolog
analys
viru
identif
perform
sampl
concord
two
techniqu
test
sensit
specif
positiveneg
predict
valu
take
bal
result
refer
result
bal
consid
adequ
patient
among
viral
pathogen
identifi
pneumoniacheck
tm
time
differ
sampl
wherea
bal
allow
detect
presenc
viru
patient
posit
overal
specif
pneumoniacheck
tm
detect
viru
wherea
sensit
consid
herp
virus
pneumoniacheck
tm
show
lower
sensit
detect
viru
infect
patient
conclus
pilot
studi
pneumoniacheck
tm
show
good
correl
bal
nonherp
virolog
identif
pneumonia
patient
provid
excel
specif
studi
larger
popul
need
confirm
result
defin
place
panorama
rapid
diagnost
test
lower
respiratori
tract
infect
lower
respiratori
tract
infect
challeng
physician
investig
aetiolog
ideal
specimen
difficult
collect
site
infect
uncommon
deal
poor
qualiti
sampl
nevertheless
rapid
precis
recognit
pathogen
still
remain
cardin
import
especi
immunosuppress
patient
due
haematolog
neoplast
posttranspl
condit
date
oropharyng
swab
induc
spontan
sputum
bronchoalveolar
lavag
bal
main
techniqu
allow
clinician
perform
microbiolog
cellular
immuneenzymat
evalu
respiratori
tract
sampl
diagnost
pathway
either
commun
acquir
pneumonia
cap
hospit
acquir
pneumonia
hap
techniqu
provid
specimen
adequ
detect
virus
often
inadequ
pathogen
ie
nasopharyng
swab
wherea
sampl
contain
contamin
upper
respiratori
tract
allow
investig
presenc
specif
pathogen
ie
sputum
lead
physician
empir
treat
infect
bal
allow
collect
specimen
directli
lung
consid
import
tool
etiolog
diagnosi
pneumonia
despit
fact
flexibl
bronchoscopi
safe
usual
well
toler
procedur
due
invas
natur
still
routin
perform
everi
patient
everi
centr
furthermor
even
techniqu
sampl
risk
contamin
pathogen
upper
respiratori
tract
date
bronchoscopi
bal
recommend
immunosuppress
patient
patient
antibiot
therapi
fail
resolv
infect
estim
cap
aetiolog
determin
endoscop
procedur
patient
especi
non
respond
antibiot
therapi
aerosol
produc
cough
valid
altern
collect
sampl
lower
respiratori
tract
alveolar
space
estim
singl
cough
aerosol
particl
gener
accord
literatur
gener
effect
cough
requir
patient
reach
l
min
l
peak
cough
expiratori
flow
pcef
measur
peak
flow
meter
normal
valu
healthi
adult
l
min
patient
affect
lower
respiratori
tract
infect
infect
peopl
dispers
air
aerosol
particl
produc
cough
sneez
matter
fact
concentr
pathogen
lung
higher
cough
sneez
aerosol
pneumoniacheck
tm
arc
medic
inc
new
devic
design
collect
specimen
lower
respiratori
tract
exhal
cough
particular
retain
aerosol
particl
dedic
filter
prevent
contamin
upper
respiratori
tract
figur
filter
analys
molecular
microbiolog
test
order
detect
presenc
differ
pathogen
fluid
mechan
principl
allow
filter
separ
aerosol
particl
lung
air
come
upper
respiratori
tract
patient
cough
devic
air
upper
respiratori
tract
flow
reservoir
offer
lower
resist
compar
filter
remind
normal
exhal
anatom
dead
space
contamin
first
volum
air
come
lung
sinc
pneumoniacheck
tm
reservoir
volum
ml
ensur
separ
aerosol
particl
upper
airway
ml
margin
averag
dead
anatom
space
furthermor
reservoir
bag
inelast
forc
subsequ
exhal
air
abovement
filter
allow
collect
lower
respiratori
tract
aerosol
figur
two
valid
studi
test
efficaci
devic
collect
sampl
respiratori
infect
evalu
concord
biomolecular
microbiolog
result
obtain
pneumoniacheck
tm
tradit
sampl
method
patient
affect
pneumonia
thu
aim
studi
prospect
singlecentr
observ
pilot
studi
conduct
accord
strobe
statement
observ
studi
approv
institut
review
board
inform
consent
collect
patient
possibl
withdraw
given
time
patient
older
year
pneumonia
cap
hap
nonproduct
cough
undergo
diagnost
bronchoscopi
bal
prospect
includ
exclus
criteria
l
min
l
measur
peak
flow
meter
vitalograph
peak
cough
flow
medic
graphic
italia
srl
milano
itali
pregnanc
evalu
pcef
sampl
pneumoniacheck
tm
bronchoscopi
bal
perform
patient
cough
procedur
devic
filter
simpli
remov
steril
pincer
immedi
put
enat
test
tube
contain
ml
virolog
conserv
fluid
copan
italia
spa
brescia
itali
first
aliquot
use
molecular
multiplex
determin
realtim
polymeras
chain
reaction
rtpcr
toce
tm
technolog
use
extractor
microlab
nimbu
ivd
hamilton
compani
anyplex
ii
kit
seegen
inc
subsequ
bronchoscopi
bal
perform
patient
determin
done
way
specimen
obtain
bal
bal
adequaci
perform
evalu
accord
intern
guidelin
patient
record
volum
fluid
recoveri
adequaci
amount
bal
fluid
destin
microbiolog
virolog
analysi
ml
virolog
test
rt
pcr
use
ml
bal
fluid
collect
amount
specimen
immedi
separ
two
aliquot
store
process
evalu
concord
result
obtain
pneumoniacheck
tm
bal
also
calcul
sensit
specif
posit
neg
predict
valu
viral
infect
pneumoniacheck
tm
data
express
mean
statist
analysi
perform
medcalc
softwar
mariakerk
belgium
decemb
februari
twelv
consecut
patient
underw
pneumoniacheck
tm
sampl
follow
bronchoscopi
pneumonia
intervent
pulmonari
unit
medium
size
teach
hospit
five
patient
hospit
wherea
seven
outpati
demograph
characterist
smoke
habit
comorbid
list
tabl
includ
hap
cap
among
patient
cap
immunocompromis
oncohematolog
disord
renal
transplant
ct
scan
pneumonia
radiolog
pattern
encount
consolid
pure
groundglass
consolid
groundglass
treeinbud
vast
major
patient
recent
treat
antibiot
take
acyclovir
prophylaxi
therapi
acyclovir
mg
none
treatment
antifung
drug
detail
day
treatment
report
tabl
five
patient
previous
receiv
season
influenza
vaccin
one
patient
pneumococc
vaccin
patient
l
min
l
measur
peak
flow
meter
specimen
collect
via
pneumoniacheck
tm
correctli
complet
sampl
obtain
bronchoscopi
consid
adequ
patient
mean
recoveri
bal
volum
ml
complic
relat
bronchoscopi
observ
viral
pathogen
identifi
pneumoniacheck
tm
time
differ
sampl
wherea
bal
allow
detect
presenc
viru
patient
posit
list
pathogen
identifi
method
report
tabl
patient
inadequ
bal
enter
statist
analysi
sinc
techniqu
consid
gold
standard
comparison
analysi
concord
rate
nonherp
virus
four
case
pneumoniacheck
tm
bal
identifi
viru
two
case
bal
identifi
viru
detect
pneumoniacheck
tm
rhinoviru
coronaviru
furthermor
one
case
pneumoniacheck
tm
detect
viru
bal
consid
inadequ
parainfluenza
viru
pneumoniacheck
tm
sensit
specif
nonherp
virus
respect
predict
posit
neg
valu
respect
data
refer
tabl
result
herp
virus
detect
pneumoniacheck
tm
bal
patient
overal
pneumoniacheck
tm
abl
identifi
patient
least
one
herp
viru
detect
bal
sensit
consid
herp
virus
detect
bal
sensit
drop
tabl
final
microbiolog
analysi
bal
specimen
allow
identifi
bacteri
pathogen
differ
patient
tabl
pilot
studi
show
pneumoniacheck
tm
use
noninvas
tool
detect
nonherpet
viral
pathogen
patient
effect
cough
concord
pneumoniacheck
tm
bal
sampl
show
high
specif
good
sensit
case
herpesviru
concord
weaker
best
knowledg
first
studi
specif
test
pneumoniacheck
tm
viru
detect
lower
respiratori
tract
infect
one
lead
caus
morbid
mortal
worldwid
incid
viral
pathogen
context
highli
variabl
among
studi
often
influenc
diagnost
techniqu
nevertheless
prompt
definit
diagnosi
remain
cornerston
manag
treatment
viral
respiratori
infect
cap
import
virus
involv
influenza
parainfluenza
respiratori
syncyti
viru
adenoviru
coronaviru
rinhoviru
detect
analys
serum
sampl
cultur
rapid
diagnost
test
enzym
immunoassay
immunofluoresc
nevertheless
introduct
pcr
increas
diagnost
yield
compar
convent
diagnost
procedur
despit
tool
remain
difficult
case
determin
whether
one
pathogen
involv
develop
infect
matter
fact
consid
detect
influenza
viru
seen
actual
etiolog
factor
colonis
thu
prudenc
requir
interpret
result
healthi
peopl
carrier
respiratori
tract
virus
pneumoniacheck
tm
new
devic
collect
microbiolog
sampl
lower
respiratori
tract
bypass
upper
respiratori
tract
avoid
possibl
contamin
recent
studi
demonstr
bacteria
virus
retain
microbi
filter
devic
test
healthi
volunt
show
absenc
contamin
even
sampl
collect
stimul
ml
liquid
moreov
analys
differ
alcohol
oxygen
level
demonstr
pneumoniacheck
tm
abl
efficaci
separ
ga
upper
lower
airway
studi
evalu
collect
proprieti
filter
test
viral
filtrat
effici
result
mean
particl
size
result
author
confirm
filter
use
pneumoniacheck
tm
abl
captur
virus
aerosol
particl
pcr
analysi
bacteri
dna
could
perform
notabl
author
evalu
efficaci
rtpcr
bacteria
virus
moreov
system
inc
produc
vbmax
filter
incorpor
pneumoniacheck
tm
use
bacteriophag
test
viral
filtrat
effici
due
diamet
bacteriophag
presum
filter
pneumoniacheck
tm
actual
abl
collect
larg
qualiti
virus
screen
rtpcr
system
rhinovirus
enterovirus
bocavirus
dimens
similar
bacteriophag
recent
ku
et
al
examin
lower
tract
infect
pneumoniacheck
tm
cystic
fibrosi
cf
patient
accord
result
sampl
collect
via
pneumoniacheck
tm
posit
cfrelat
bacteria
none
show
contamin
commens
bacteria
compar
contamin
sputum
sampl
nevertheless
patient
medic
histori
peculiar
wellknown
physician
test
perform
bacteria
like
present
airway
studi
decid
focu
attent
viral
pathogen
difficult
detect
compar
bacteri
one
sinc
biolog
sampl
like
naiv
antimicrobi
treatment
reduc
risk
bia
accord
literatur
preval
viru
isol
bal
fluid
patient
cap
hap
estim
higher
case
transplant
patient
one
drawback
bal
risk
obtain
inadequ
specimen
due
variabl
sampl
procedur
matter
fact
cohort
bal
sampl
consid
inadequ
definit
diagnosi
convers
pneumoniacheck
tm
collect
adequ
virolog
analysi
show
good
abil
devic
obtain
good
sampl
array
virus
isol
pneumoniacheck
tm
line
commun
acquir
respiratori
virus
herp
simplex
viru
viru
influenza
epsteinbarr
viru
human
herp
viru
viru
parainfluenza
rhinoviru
synciti
respiratori
viru
case
influenza
viru
present
cohort
detect
bal
pneumoniacheck
tm
cohort
identifi
larg
number
herp
viru
posit
bal
one
pneumoniacheck
tm
sampl
one
hand
must
consid
bal
give
larg
amount
sampl
molecular
multiplex
determin
wherea
filter
pneumoniacheck
tm
ml
conserv
fluid
use
rt
pcr
test
herp
virus
hand
necessari
highlight
role
famili
virus
pathogenesi
lower
respiratori
tract
infect
immunocompromis
immunocompet
host
latter
group
infect
usual
asymptomat
mononucleosislik
syndrom
cours
occasion
primari
cytomegaloviru
cmv
infect
evolv
sever
organspecif
manifest
furthermor
previous
mention
mani
patient
may
display
colonis
herp
virus
thu
posit
pcr
might
suffici
distinguish
asymptomat
colonis
activ
infect
convers
quantif
viral
load
bal
fluid
could
potenti
differenti
two
condit
moreov
herp
virus
transmiss
clinic
challeng
particular
clinician
involv
transplant
protocol
situat
major
infect
consequ
reactiv
latent
infect
herp
virus
transmiss
occur
usual
inhal
oral
secret
literatur
studi
evalu
viru
colon
droplet
lack
reason
detail
regard
patienttopati
transmiss
virus
matter
discuss
howev
know
pneumoniacheck
tm
collect
particl
origin
lower
airway
mainli
dead
space
give
sampl
colon
virus
furthermor
must
consid
differ
virus
differ
target
airway
fact
nonherp
virus
respons
bigger
part
viral
pneumonia
colon
bronchial
surfac
sometim
alveolar
one
contrari
herp
virus
usual
colon
upper
airway
rare
lower
one
could
partial
explain
result
sinc
upper
airway
exclud
sampl
addit
sinc
bal
fluid
collect
higher
number
virus
cell
infect
wash
alveolar
bronchial
surfac
possibl
evalu
presenc
virus
qpcr
lead
higher
quantit
result
believ
use
pneumoniacheck
tm
specif
popul
make
easier
identif
specif
agent
risk
ignor
presenc
one
compar
studi
ku
et
al
includ
consecut
patient
pneumonia
underw
bronchoscopi
univers
hospit
pulmonari
unit
popul
studi
known
diagnost
pathway
requir
larger
displac
diagnost
tool
thu
narrow
list
possibl
implic
pathogen
improv
accuraci
result
decid
test
pneumoniacheck
tm
specif
viru
detect
found
devic
high
specif
facilit
detect
noninfect
patient
lower
sensit
nevertheless
latter
may
influenc
small
number
subject
includ
studi
type
viru
matter
fact
compar
nonherp
virus
herp
virus
difficult
detect
lower
sensit
devic
subpopul
two
crucial
mainstay
point
studi
first
patient
test
peak
flow
meter
pneumoniacheck
tm
use
order
verifi
presenc
effect
cough
precaut
taken
studi
ku
et
al
allow
us
look
adequaci
pneumoniacheck
tm
sampl
indirect
valid
second
compar
new
devic
bal
time
gold
standard
diagnosi
studi
limit
first
small
number
subject
includ
may
influenc
result
particular
sensit
pneumoniacheck
tm
nevertheless
pilot
studi
patient
inclus
well
new
trial
could
clarifi
issu
second
microbiolog
analys
limit
virolog
sampl
exclud
standard
bacteri
fungal
cultur
nevertheless
restrict
amount
biolog
sampl
collect
filter
pneumoniacheck
tm
would
suffici
complet
investig
wide
rang
possibl
involv
bacteria
nonselect
popul
convers
issu
could
becom
strength
devic
could
allow
rapid
identif
bacteria
virus
specif
highlyselect
popul
lung
transplant
cf
patient
final
anoth
limit
devic
filter
power
filter
use
pneumoniacheck
tm
great
portion
aerosol
size
exhal
air
rang
reason
neg
pneumoniacheck
tm
result
contrast
posit
obtain
bal
nevertheless
demonstr
lindsay
et
al
high
number
influenza
rna
could
found
also
particl
aerodynam
diamet
greater
reason
think
even
filter
collect
effici
signific
number
particl
carri
virus
collect
pneumoniacheck
tm
new
devic
safe
easi
use
collect
lower
airway
pathogen
cough
aerosol
show
good
correl
bal
nonherp
virolog
identif
patient
pneumonia
provid
excel
specif
good
sensit
studi
larger
popul
need
confirm
result
find
correct
place
pneumoniacheck
tm
panorama
rapid
diagnost
test
patient
lower
tract
respiratori
infect
